179 related articles for article (PubMed ID: 2547390)
1. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
Borella LE; DiJoseph JF
Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
[TBL] [Abstract][Full Text] [Related]
2. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
3. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
4. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
[TBL] [Abstract][Full Text] [Related]
6. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of UP 5145-52, an original antiulcer and antisecretory agent.
Dedieu-Chaufour C; Hertz F; Caussade F; Cloarec A
J Pharmacol Exp Ther; 1991 Oct; 259(1):190-7. PubMed ID: 1656018
[TBL] [Abstract][Full Text] [Related]
8. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
9. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory and cytoprotective activities of SCH 28080.
Long JF; Chiu PJ; Derelanko MJ; Steinberg M
J Pharmacol Exp Ther; 1983 Jul; 226(1):114-20. PubMed ID: 6864535
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
12. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
DiJoseph JF; Eash JR; Mir GN
J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
[TBL] [Abstract][Full Text] [Related]
13. Gastric antisecretory and antiulcer effects of simvastatin in rats.
Tariq M; Khan HA; Elfaki I; Arshaduddin M; Al Moutaery M; Al Rayes H; Al Swailam R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2316-23. PubMed ID: 17593225
[TBL] [Abstract][Full Text] [Related]
14. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106
[TBL] [Abstract][Full Text] [Related]
15. Gastric anti-ulcer and cytoprotective properties of 2-(3,4-dimethoxyphenyl)-5-methyl-thiazolidine-4-one in rat experimental ulcers.
Matsuo Y; Kuwayama H; Itoh H; Seki A; Fukuda S; Kawasaki T; Hotta T; Ohsaka Y; Komatsu K
Arzneimittelforschung; 1986 Aug; 36(8):1236-40. PubMed ID: 3778561
[TBL] [Abstract][Full Text] [Related]
16. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
17. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat.
Borella LE; DiJoseph JF; Mir GN
Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
